Literature DB >> 16214815

Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome.

Jeffrey C Horowitz1, Zongbin Cui, Thomas A Moore, Tamara R Meier, Raju C Reddy, Galen B Toews, Theodore J Standiford, Victor J Thannickal.   

Abstract

Acute respiratory distress syndrome (ARDS) is a clinical syndrome characterized by stereotypic host inflammatory and repair cellular responses; however, mechanisms regulating the resolution of ARDS are poorly understood. Here, we report the isolation and characterization of a novel population of mesenchymal cells from the alveolar space of ARDS patients via fiber-optic bronchoscopy with bronchoalveolar lavage (BAL). BAL was performed on 17 patients during the course of ARDS. Immunofluorescence staining and multiparameter flow cytometric analysis defined a population of alveolar mesenchymal cells (AMCs) that are CD45-/prolyl-4-hydroxylase+/alpha-smooth muscle actin+/-. AMCs proliferated in ex vivo cell culture for multiple passages; early passage (3-5) cells were subsequently analyzed in 13 patients. AMCs isolated from patients with persistent or nonresolving ARDS (ARDS-NR, n = 4) demonstrate enhanced constitutive activation of prosurvival signaling pathways involving PKB/Akt, FKHR, and BCL-2 family proteins compared with AMCs from patients with resolving ARDS (ARDS-R, n = 9). Exogenous transforming growth factor-beta1 markedly induces PKB/Akt activation in AMCs from ARDS-R. ARDS-NR cells are more resistant to serum deprivation-induced apoptosis compared with ARDS-R. This study identifies a novel population of mesenchymal cells that can be isolated from the alveolar spaces of ARDS patients. AMCs in patients with ARDS-NR acquire an activational profile characterized by enhanced prosurvival signaling and an antiapoptotic phenotype. These findings support the concept that apoptosis of mesenchymal cells may be an essential component of normal repair and resolution of ARDS and suggest that dysregulation of this process may contribute to persistent ARDS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214815      PMCID: PMC1382273          DOI: 10.1152/ajplung.00276.2005

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  57 in total

Review 1.  The acute respiratory distress syndrome.

Authors:  Claude A Piantadosi; David A Schwartz
Journal:  Ann Intern Med       Date:  2004-09-21       Impact factor: 25.391

2.  Diversity, topographic differentiation, and positional memory in human fibroblasts.

Authors:  Howard Y Chang; Jen-Tsan Chi; Sandrine Dudoit; Chanda Bondre; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-24       Impact factor: 11.205

Review 3.  PKB binding proteins. Getting in on the Akt.

Authors:  Derek P Brazil; Jongsun Park; Brian A Hemmings
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

Review 4.  Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome.

Authors:  Jean-François Dhainaut; Julien Charpentier; Jean-Daniel Chiche
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

5.  TGF-beta1 induces alveolar epithelial to mesenchymal transition in vitro.

Authors:  Hong-Wei Yao; Qiang-Min Xie; Ji-Qiang Chen; Yang-Mei Deng; Hui-Fang Tang
Journal:  Life Sci       Date:  2004-11-19       Impact factor: 5.037

6.  Bone marrow-derived progenitor cells in pulmonary fibrosis.

Authors:  Naozumi Hashimoto; Hong Jin; Tianju Liu; Stephen W Chensue; Sem H Phan
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

7.  Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor.

Authors:  Jeffrey C Horowitz; Daniel Y Lee; Meghna Waghray; Venkateshwar G Keshamouni; Peedikayil E Thomas; Hengmin Zhang; Zongbin Cui; Victor J Thannickal
Journal:  J Biol Chem       Date:  2003-10-23       Impact factor: 5.157

8.  Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt.

Authors:  Laura Asnaghi; Angela Calastretti; Annamaria Bevilacqua; Igea D'Agnano; Giuliana Gatti; Gianfranco Canti; Domenico Delia; Sergio Capaccioli; Angelo Nicolin
Journal:  Oncogene       Date:  2004-07-29       Impact factor: 9.867

9.  Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.

Authors:  Roderick J Phillips; Marie D Burdick; Kurt Hong; Marin A Lutz; Lynne A Murray; Ying Ying Xue; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

10.  Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors.

Authors:  Véronique Moulin; Sébastien Larochelle; Céline Langlois; Isabelle Thibault; Carlos A Lopez-Vallé; Michel Roy
Journal:  J Cell Physiol       Date:  2004-03       Impact factor: 6.384

View more
  28 in total

1.  Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts.

Authors:  Jeffrey C Horowitz; David S Rogers; Vishal Sharma; Ragini Vittal; Eric S White; Zongbin Cui; Victor J Thannickal
Journal:  Cell Signal       Date:  2006-11-17       Impact factor: 4.315

2.  Nuclear factor-kappaB activation in neonatal mouse lung protects against lipopolysaccharide-induced inflammation.

Authors:  Cristina M Alvira; Aida Abate; Guang Yang; Phyllis A Dennery; Marlene Rabinovitch
Journal:  Am J Respir Crit Care Med       Date:  2007-01-25       Impact factor: 21.405

Review 3.  Therapeutic targeting of acute lung injury and acute respiratory distress syndrome.

Authors:  Theodore J Standiford; Peter A Ward
Journal:  Transl Res       Date:  2015-05-05       Impact factor: 7.012

4.  WNT/β-catenin signaling is modulated by mechanical ventilation in an experimental model of acute lung injury.

Authors:  Jesús Villar; Nuria E Cabrera; Milena Casula; Francisco Valladares; Carlos Flores; Josefina López-Aguilar; Lluis Blanch; Haibo Zhang; Robert M Kacmarek; Arthur S Slutsky
Journal:  Intensive Care Med       Date:  2011-05-13       Impact factor: 17.440

Review 5.  Epithelial-mesenchymal interactions in pulmonary fibrosis.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Semin Respir Crit Care Med       Date:  2006-12       Impact factor: 3.119

6.  The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.

Authors:  E S Gad; A A A Salama; M F El-Shafie; H M M Arafa; R M Abdelsalam; M Khattab
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

7.  X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis.

Authors:  Iyabode O Ajayi; Thomas H Sisson; Peter D R Higgins; Adam J Booth; Rommel L Sagana; Steven K Huang; Eric S White; Jessie E King; Bethany B Moore; Jeffrey C Horowitz
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

8.  Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation.

Authors:  Priya Kulasekaran; Casey A Scavone; David S Rogers; Douglas A Arenberg; Victor J Thannickal; Jeffrey C Horowitz
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-02       Impact factor: 6.914

9.  Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts.

Authors:  Thomas H Sisson; Toby M Maher; Iyabode O Ajayi; Jessie E King; Peter D R Higgins; Adam J Booth; Rommel L Sagana; Steven K Huang; Eric S White; Bethany B Moore; Jeffrey C Horowitz
Journal:  Adv Biosci Biotechnol       Date:  2012-10

10.  Lung fibroblasts accelerate wound closure in human alveolar epithelial cells through hepatocyte growth factor/c-Met signaling.

Authors:  Yoko Ito; Kelly Correll; John A Schiel; Jay H Finigan; Rytis Prekeris; Robert J Mason
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-04-18       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.